Curated summary · agent-written · kb/genes/curated/hgnc_603.md
All 16 claims checked against the KB draft

APOB across dismech

APOB (apolipoprotein B) is named by 5 disorder entries. It encodes apolipoprotein B, the structural protein of chylomicrons, VLDL and LDL particles.

Normal function

The pinned ai-gene-review snapshot that the ingest layer reads has no core functions for APOB (0 terms). An upstream review of the gene is being added or updated.

Causative records

The entries that type APOB as causative are Familial Defective Apolipoprotein B-100; Hypobetalipoproteinemia, and the germline-origin causative entries are Familial Defective Apolipoprotein B-100; Hypobetalipoproteinemia. ClinGen rates the gene definitive for familial defective apolipoprotein B-100 and definitive for hypobetalipoproteinemia.

In Familial Defective Apolipoprotein B-100 the gene sits on the nodes APOB Receptor-Binding-Region Missense Variant and Defective ApoB-100 Binding to a Structurally Normal LDL Receptor. In Hypobetalipoproteinemia it sits on APOB Truncating Variant and Impaired Hepatic and Intestinal ApoB-Lipoprotein Assembly and Secretion. The KB's mechanism annotations for APOB name the processes cholesterol metabolic process; low-density lipoprotein particle clearance; receptor-mediated endocytosis; very-low-density lipoprotein particle assembly.

Other entries

MEND Syndrome records APOB as modifier. The entries with a genetic record for APOB that carries no relationship type are Familial Hypercholesterolemia; Hyperlipidemia.

Where the layers disagree

Because the pinned ai-gene-review snapshot has no core functions for the gene, the KB and ai-gene-review currently share 0 GO process terms.

Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.

In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Familial Defective Apolipoprotein B-100 causative germline partial loss of function
CLINGEN: definitive
mechanism: APOB Receptor-Binding-Region Missense Variant; Defective ApoB-100 Binding to a Structurally Normal LDL Receptor
Hypobetalipoproteinemia causative germline loss of function
CLINGEN: definitive
mechanism: APOB Truncating Variant; Impaired Hepatic and Intestinal ApoB-Lipoprotein Assembly and Secretion
subtype: FHBL1 Heterozygous; FHBL1 Homozygous
diagnosis: APOB molecular genetic testing
MEND Syndrome modifier
Familial Hypercholesterolemia untyped
Pathogenic Mutations
mechanism: APOB-LDLR Binding Defect
treatment: Mipomersen
Hyperlipidemia untyped
Monogenic Cause and ApoB-Trafficking Determinant
mechanism: Impaired Hepatic ApoB-Containing Lipoprotein Clearance
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
hypercholesterolemia, autosomal dominant, type B MONDO:0007751 AD Definitive
2018-11-14
familial hypobetalipoproteinemia 1 MONDO:0014252 SD Definitive
2020-02-26

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.